clinical trial · NCT05037929
A Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
Genentech, Inc.·phase2·completed·n = 1,334
Chronic Obstructive Pulmonary DiseaseAstegolimabPlacebo
brief summary
This study will evaluate the efficacy, safety, and pharmacokinetics of astegolimab in combination with standard of care chronic obstructive pulmonary disease (COPD) maintenance therapy in patients with COPD who are former or current smokers and have a history of frequent exacerbations.
started
Oct 5, 2021
primary completion
Feb 24, 2025
completion
Jul 7, 2025
last updated
Feb 25, 2026
official title
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Astegolimab in Patients With Chronic Obstructive Pulmonary Disease
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol